CRISM Therapeutics Corporation

Research CRISM Therapeutics Corporation (CRTX) on Bullrun: market cap GBX 761.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRTX
• ExchangeLSE
• CountryBritish Virgin Islands
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 761.76M
• Financial periodFY2024
• RevenueGBP 25.00K
• Revenue growth-44.4%
• Net income-GBP 607.00K
• Free cash flow-GBP 961.00K
• Gross margin84.0%

Valuation Snapshot

latest market cap is GBX 761.76M.

About CRISM Therapeutics Corporation

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services.

Frequently asked questions

What is CRISM Therapeutics Corporation's market cap?

CRISM Therapeutics Corporation's market capitalization is GBX 761.76M.

What does CRISM Therapeutics Corporation do?

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.